Page last updated: 2024-08-23

plicamycin and Leukemia, Erythroblastic, Acute

plicamycin has been researched along with Leukemia, Erythroblastic, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cotter, TG; Duverger, V; England, K; Hayes, I; Murphy, AM; Murphy, FJ; Sheehan, D	1

Other Studies

1 other study(ies) available for plicamycin and Leukemia, Erythroblastic, Acute

Article	Year
The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF). British journal of cancer, 2004, May-17, Volume: 90, Issue:10 Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Carrier Proteins; Drug Resistance, Neoplasm; fas Receptor; Fas-Associated Death Domain Protein; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Promyelocytic, Acute; Plicamycin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2004

Article

Year

The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF).

British journal of cancer, 2004, May-17, Volume: 90, Issue:10

Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Carrier Proteins; Drug Resistance, Neoplasm; fas Receptor; Fas-Associated Death Domain Protein; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Promyelocytic, Acute; Plicamycin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2004